Equity Profile

IQV

IQVIA Holdings Inc.

Health CareLife Sciences Tools & Services$30.6B

May5Tue

Post-Earnings Recap

ReportedQ1-2026Pre-Market7:00 AM EDT

IQVIA Holdings Inc. Beats on EPS, Stock Up 9.62%

Metric	Actual	Expected	Surprise
EPS	$2.90	$2.82	+15.68%
Revenue	—	$4.1B	—

management commentary, guidance changes, and full analysis available with Pro.

IQVIA Holdings Inc. Beats on EPS, Stock Up 9.62%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$2.90	$2.82	+15.68%
Revenue	—	$4.1B	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

IQVIA's strong EPS performance exceeded analyst expectations, contributing to a significant stock increase of 9.62%. However, the lack of revenue data and management commentary leaves some uncertainty about the overall business outlook. Investors may be encouraged by the earnings beat but will likely be looking for more information in future reports.

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to the life sciences industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$2.82

Revenue

Revenue figures will provide insight into the overall demand for IQVIA's services and how well it is capturing market opportunities.

$4.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to the life sciences industry. With a market cap of $26 billion, the company plays a crucial role in helping pharmaceutical and biotech companies improve their research and development processes.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q4-2025, IQVIA reported an EPS of $3.42, exceeding expectations by 9.16%. However, the stock fell 10.65% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IQVIA to continue its trend of beating earnings estimates, with a consensus EPS of $2.82. However, the stock's recent volatility suggests that any surprises could lead to significant price movements.

Bull Case

If IQVIA delivers strong earnings and revenue growth, it could reinforce investor confidence and lead to a positive stock reaction, especially given its history of beating estimates.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could trigger a sharp decline in the stock price, reflecting ongoing market skepticism.

Key Metrics to Watch

EPS

$2.82

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$4.1B

Revenue figures will provide insight into the overall demand for IQVIA's services and how well it is capturing market opportunities.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will IQVIA's EPS exceed the consensus estimate of $2.82?

A beat on EPS could indicate strong operational performance and boost investor confidence, while a miss could raise concerns about the company's growth trajectory.

What guidance will management provide regarding future revenue growth?

Management's outlook on revenue growth will be critical for assessing the company's ability to navigate market challenges and capitalize on opportunities.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate IQVIA's ability to leverage new technology solutions that could drive higher revenue growth than anticipated.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating stronger operational performance than analysts expect.

The options market is pricing in a larger move than historical averages suggest, indicating potential for a surprise.

Recent insider activity shows mixed signals, which may imply uncertainty about future performance.

Key Risk

If the company reports revenue growth significantly above $4.1 billion, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching IQVIA's ability to deliver consistent earnings and revenue growth amidst a competitive landscape.

Bull Confirmed If

An EPS of $2.90 or higher, along with revenue growth exceeding $4.1 billion, would confirm the bullish case.

Bear Confirmed If

An EPS below $2.70 and revenue failing to meet expectations would validate the bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±9.65%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.

Options are pricing ±9.8% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

37.5%

Calls (18K)P/C Ratio: 5.56Puts (100K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations, history suggests a potential stock increase of around +0.7%, confirming the company's strong performance.

In-Line / Cautious

An in-line report may lead to muted reactions, with management's commentary driving the stock's direction based on future outlook.

Miss

If IQVIA misses estimates, the stock could decline significantly, as seen in past quarters with average drops following misses.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·1 sell

Members

House + Senate

Est. Notional

$65,002.00–$150,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive future revenue.
2Management's commentary on cost management and operational efficiency.
3Insights into market demand for IQVIA's services in the life sciences sector.
4Any changes in guidance for the upcoming quarters.
5Discussion on competitive pressures and how IQVIA plans to address them.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to the life sciences industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$2.82

Revenue

Revenue figures will provide insight into the overall demand for IQVIA's services and how well it is capturing market opportunities.

$4.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q4-2025, IQVIA reported an EPS of $3.42, exceeding expectations by 9.16%. However, the stock fell 10.65% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If IQVIA delivers strong earnings and revenue growth, it could reinforce investor confidence and lead to a positive stock reaction, especially given its history of beating estimates.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could trigger a sharp decline in the stock price, reflecting ongoing market skepticism.

Key Metrics to Watch

EPS

$2.82

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$4.1B

Revenue figures will provide insight into the overall demand for IQVIA's services and how well it is capturing market opportunities.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will IQVIA's EPS exceed the consensus estimate of $2.82?

A beat on EPS could indicate strong operational performance and boost investor confidence, while a miss could raise concerns about the company's growth trajectory.

What guidance will management provide regarding future revenue growth?

Management's outlook on revenue growth will be critical for assessing the company's ability to navigate market challenges and capitalize on opportunities.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate IQVIA's ability to leverage new technology solutions that could drive higher revenue growth than anticipated.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating stronger operational performance than analysts expect.

The options market is pricing in a larger move than historical averages suggest, indicating potential for a surprise.

Recent insider activity shows mixed signals, which may imply uncertainty about future performance.

Key Risk

If the company reports revenue growth significantly above $4.1 billion, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching IQVIA's ability to deliver consistent earnings and revenue growth amidst a competitive landscape.

Bull Confirmed If

An EPS of $2.90 or higher, along with revenue growth exceeding $4.1 billion, would confirm the bullish case.

Bear Confirmed If

An EPS below $2.70 and revenue failing to meet expectations would validate the bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±9.65%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.

Options are pricing ±9.8% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

37.5%

Calls (18K)P/C Ratio: 5.56Puts (100K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations, history suggests a potential stock increase of around +0.7%, confirming the company's strong performance.

In-Line / Cautious

An in-line report may lead to muted reactions, with management's commentary driving the stock's direction based on future outlook.

Miss

If IQVIA misses estimates, the stock could decline significantly, as seen in past quarters with average drops following misses.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·1 sell

Members

House + Senate

Est. Notional

$65,002.00–$150,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive future revenue.
2Management's commentary on cost management and operational efficiency.
3Insights into market demand for IQVIA's services in the life sciences sector.
4Any changes in guidance for the upcoming quarters.
5Discussion on competitive pressures and how IQVIA plans to address them.